The pound was quoted at USD1.3009 early Wednesday, rising from USD1.2991 at the London equities close on Tuesday. The euro stood at USD1.0825, climbing from USD1.0795. Against the yen, the dollar was ...

(Alliance News) - The armed forces of the UK are in line for a GBP3 billion boost, according to reports, as Rachel Reeves prepares to unveil the Labour government's first budget.

(Alliance News) - Challenger Energy Group PLC on Tuesday said that it has completed the farmout of a 60% interest in the Area Off-1 block to Chevron Mexico Finance LLC. Accordingly, the Atlantic ...

Shield has agreed to expand its existing working capital arrangement with Sallyport Commercial Finance by 50% to USD15 million from USD10 million. The firm is also reducing its operating cost base by ...

The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: IQE PLC - Cardiff-based supplier of compound ...

(Alliance News) - GSK PLC on Tuesday said that it has signed a deal to buy CMG1A46 from Chimagen Biosciences for USD300 million upfront. The London-based pharmaceutical and biotechnology firm plans to ...

Likewise Group PLC - Birmingham, England-based floor coverings distributor - Non-Executive Director Andrew Simpson sells 9.3 million shares at 15 pence, worth GBP1.4 million, on Monday. Likewise says ...

The London-based oil major said replacement cost profit for the third quarter that ended September 30 was USD1.11 billion, falling 70% from USD3.65 billion last year. Underlying RC profit fell 31% to ...

(Alliance News) - The UK and the EU reached an agreement on Tuesday that will allow the two sides' regulators to work closely together on competition matters. The UK and the EU struck a landmark trade ...

In line with its progressive dividend policy YouGov recommended a 2.9% increase in its dividend to 9.0 pence a share, up from 8.75p the previous year. This is to be approved by shareholders at the ...

Seplat Energy declared an interim dividend of 3.60 cents per share, up 20% from 3.00 cents in the second quarter and 3.00 cents in the third quarter of 2023. Shares in the company were down 0.9% at ...

The Cambridge, England-based pharmaceutical company focused on developing next-generation kinase inhibitors for autoimmune disease and cancer said pretax loss widened to GBP4.6 million in the ...